Vicore Pharma Holding AB (publ) (VICO) — Capital Reinvestment Ratio
Latest as of September 2018:
7.73x
Vicore Pharma Holding AB (publ) (VICO) has a Capital Reinvestment Ratio of 7.73x as of September 2018, meaning it reinvests 8% of its operating cash flow (Skr700.00K) in capital expenditures (Skr5.41 Million). See Vicore Pharma Holding AB (publ) balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
7.73x
Capex / Operating Cash Flow
Operating Cash Flow
Skr700.00K
SEK
Capital Expenditures
Skr5.41 Million
SEK
Data as of
Sep 2018
Most recent filing
Annual Capital Reinvestment Ratio for Vicore Pharma Holding AB (publ) (None–None)
Year-by-year Capital Reinvestment Ratio for Vicore Pharma Holding AB (publ) from None to None. For live market cap and broader valuation context, see VICO market cap.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow